An Honours Bachelor's degree with minimum 2:1 award (NFQ level 8) or international equivalence in a relevant Engineering, Science or Technology degree programme.

You may be eligible for Recognition of Prior Learning (RPL), as UCD recognises formal, informal, and/or experiential learning. RPL may be awarded to gain Admission and/or credit exemptions on a programme. Please visit the UCD Registry RPL web page for further information. Any exceptions are also listed on this webpage.

January

This course is typically suited for people with the following Career Interests. If these interests do not describe you, this course may prepare you for work you may not find satisfying.

Realist

Realists are usually interested in 'things' - such as buildings, mechanics, equipment, tools, electronics etc. Their primary focus is dealing with these - as in building, fixing, operating or designing them. Involvement in these areas leads to high manual skills, or a fine aptitude for practical design - as found in the various forms of engineering.

Realists like to find practical solutions to problems using tools, technology and skilled work. Realists usually prefer to be active in their work environment, often do most of their work alone, and enjoy taking decisive action with a minimum amount of discussion and paperwork.

Investigative

The Investigative person will usually find a particular area of science to be of interest. They are inclined toward intellectual and analytical activities and enjoy observation and theory. They may prefer thought to action, and enjoy the challenge of solving problems with sophiscticated technology. These types prefer mentally stimulating environments and often pay close attention to developments in their chosen field.

The Professional Certificate is suitable for Science and Engineering graduates currently working in the biopharmaceutical industry or looking to move into the sector, who wish to expand their skill set to take advantage of the growth in the vaccine, and cell and gene therapies space. The number of companies active in this area is currently growing with Pfizer, Takeda, WuXi, MeiraGTx, VLE, Avectas, Onk and Orbsen Therapeutics leading the way.

Further Study
The credits gained can be used (RPL) toward further postgraduate qualifications offered by UCD should participants wish to pursue a higher qualification e.g. Graduate Certificate (30 credits) / Graduate Diploma (60 credits)/ MEngSc in Biopharmaceutical Engineering (90 credits).